CU Cancer Center’s Associate Director for Global Oncology, Enrique Soto Pérez de Celis (Enrique Soto), MD, PhD, returned from Mexico, where he signed the first of what he hopes will be many partnership agreements with cancer centers in Latin America ⬇️ news.cuanschutz.edu/cancer-center/…

We're about 2 weeks away from the 2025 State of the School! See medschool.cuanschutz.edu/stateofthescho… for more details.

Our fellows are headed to #GI25! Be sure to stop by and say hi to Dr. Balmaceda, today at the Poster Session A!

Dr. Ueberroth will be presenting at #GI25 Poster Session B tomorrow, don't forget to check it out!

CU Cancer Center's Daniel Pollyea, MD, MS, has been honored by the Leukemia & Lymphoma Society (@llsusa) for his research on leukemia stem cells and his efforts to develop drugs that can target these cells, leading to impactful treatments ⬇️ news.cuanschutz.edu/cancer-center/…

After a leukemia diagnosis, Matt Lubick enrolled in a clinical trial led by CU Cancer Center member Daniel Pollyea, MD, MS. On the first day of chemotherapy, Lubick walked a marathon in the halls of our clinical partner uchealth's University of Colorado Hospital. FOX Sports

This week we celebrate our outstanding housestaff and their dedication, tireless efforts, and unwavering commitment to patient care. Thank you for all you do - we are incredibly grateful for your hard work and the future of medicine you represent. #CUAnschutz #CUCancer

Although our understanding of cancer is greater than at any other point in history, cancer continues to be a leading cause of death due to lack of intervention. #worldcancerday allows us to come together to raise awareness about cancer risks, prevention, detection, & treatment.

CU Cancer Center member Manali Kamdar, MD, started to think about pivoting from her dream of being a dancer to a different profession after receiving care for a spinal injury. Now she is a highly recognized leading lymphoma researcher ⬇️ bit.ly/40Sryfh

Check out our case report of an unusual presentation of ALK positive lung cancer now out in JCO Precision Oncology! I had the tremendous honor of working on this with two giants of oncology, Drs. Paul Bunn and Larry Einhorn. ascopubs.org/doi/10.1200/PO…

I just contacted my congressional representatives through AACR and called upon them to restore stability to the NIH and protect medical research. It's easy to do and I encourage all of my fellow AACR members to do the same. votervoice.net/Shares/BAAAAAI…

CU Cancer Center member Jennifer Diamond, MD, is returning to her role as medical director of the cancer center’s Cancer Clinical Trials Office (CCTO)! 👏 In this Q&A, Diamond shares how the CCTO is expanding access to clinical trials: news.cuanschutz.edu/cancer-center/…

Always a great time with the fellowship crew! 🎳🍕

It’s that time of year! Excited for a great ASCO meeting #ASCO2025 CU Anschutz Hematology/Oncology Fellowship ASCO

📸 All smiles in Chicago! At the 2025 ASCO Annual Meeting, the CU Cancer Center connected with fellow oncology leaders on the latest developments in cancer care. #ASCO25

Grateful for Conquer Cancer, the ASCO Foundation and all my mentors at CU Cancer Center including Marco Del Chiaro and Dr. Chris Lieu. Through the ASCO YIA, I will study ctDNA and peritoneal tumor DNA to evaluate response to intraperitoneal chemo for pancreatic cancer with peritoneal mets. CU Anschutz Hematology/Oncology Fellowship

Watch our interview from #EHA2025 with Maria Amaya of CU Anschutz Hematology/Oncology Fellowship to hear the results from a clinical study evaluating the safety & efficacy of an all-oral regimen of CC-486 plus venetoclax in AML: 👉 ow.ly/aR7b50WfVSG 👈 #AMLsm #Leusm #Leukemia #CTSM European Hematology Association

Orientation week is over and we are excited to have the new first years on rotation with us! #CUAnschutz #CUCancer #Welcome